Concepedia

Publication | Open Access

NVR 3-778, a First-in-Class HBV Core Inhibitor, Alone and in Combination with Peg-Interferon (PegIFN), in Treatment-Naive HBeAg-Positive Patients: Early Reductions in HBV DNA and HBeAg

33

Citations

0

References

2016

Year

No additional data available for this publication yet. Check back later!